By Crispin Dowler2015-12-18T12:43:00
NHS England’s chief financial officer has warned the board of a “substantial risk” that costs will ”significantly” outstrip the budget he has set for specialised commissioning next year, due to an ‘unprecedented stream’ of new and expensive drugs and treatments.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud